Suraksha Diagnostic Limited (NSE:SURAKSHA)

Suraksha Diagnostic Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Operating Activities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Net Income	418.21	321.87	318.24	236.25	65.16	208.24
Depreciation & Amortization	451.63	408.99	347.86	321.96	313.06	278.13
Other Amortization	5.5	5.5	5.12	4.02	3.65	5.82
Loss (Gain) From Sale of Assets	0.62	2.93	2.56	21.45	24.33	14.15
Asset Writedown & Restructuring Costs	5.42	-	-	7.79	-	-
Stock-Based Compensation	4.39	8.53	2.11	-	-	-
Provision & Write-off of Bad Debts	4.74	4.74	24.54	5.37	-	0.72
Other Operating Activities	141.42	85.66	36.43	44.88	-13.53	107.01
Change in Accounts Receivable	-125.38	-91.73	-72.12	-47.31	24.82	-15.71
Change in Inventory	-14.81	-0.83	-13.71	-5.16	0.63	-17.81
Change in Accounts Payable	80.6	74.3	-5.19	3.54	4.81	16.51
Change in Other Net Operating Assets	66.98	-1.66	-12.24	12.04	18.03	-18.83
Operating Cash Flow	1,039	818.29	633.59	604.81	440.96	578.23
Operating Cash Flow Growth	65.58%	29.15%	4.76%	37.16%	-23.74%	145.93%

Investing Activities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Capital Expenditures	-774.74	-673.45	-420.24	-454.72	-131.67	-192.49
Sale of Property, Plant & Equipment	1.67	0.95	1.41	25.52	6.61	3.44
Cash Acquisitions	-	-32.71	-10	-	-	-
Investment in Securities	-34.31	157.37	-2.6	47.36	-108.26	-260.93
Other Investing Activities	28.03	26.15	35.59	31.9	25.37	17.17
Investing Cash Flow	-779.34	-521.7	-395.84	-349.95	-207.95	-432.81

Financing Activities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Long-Term Debt Issued	-	0.77	-	5	20.5	95.91
Long-Term Debt Repaid	-	-284.85	-235.12	-254.24	-250.82	-223.74
Lease Payments	-264.38	-241.17	-207	-195.55	-180.12	-153.79
Net Debt Issued (Repaid)	-226.77	-284.07	-235.12	-249.24	-230.32	-127.83
Other Financing Activities	2.42	-2.85	-5.37	-2.05	-12.96	-15.02
Financing Cash Flow	-224.34	-286.92	-240.48	-251.29	-243.28	-142.85

Net Cash Flow

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Net Cash Flow	35.62	9.67	-2.73	3.57	-10.27	2.57

Free Cash Flow

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Free Cash Flow	264.57	144.85	213.35	150.09	309.29	385.74
Free Cash Flow Growth	53.89%	-32.11%	42.15%	-51.47%	-19.82%	375.57%
Free Cash Flow Margin	7.63%	4.67%	8.46%	6.86%	16.27%	17.28%
Free Cash Flow Per Share	5.08	2.78	4.10	2.82	5.80	7.24
Levered Free Cash Flow	323.99	48.93	89.41	45.72	270.18	287.95
Unlevered Free Cash Flow	421.69	127.39	141.82	100.64	326.8	343.23
Free Cash Flow After Leases	0.19	-96.32	6.35	-45.46	129.17	231.95

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash Interest Paid	2.85	2.85	6.37	9.08	12.96	15.02
Cash Income Tax Paid	133.58	133.58	105.82	86.1	71.93	27.96
Change in Working Capital	7.4	-19.91	-103.26	-36.9	48.29	-35.84

Data Source: S&P Global Market Intelligence Last updated: Nov 10, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 11, 2026

Data Sources Report a data error